Nissay Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $48.9M | Sell |
99,415
-101,333
| -50% | -$55M | 0.26% | 63 |
|
|
2025
Q4 | $116M | Buy |
200,748
+147,682
| +278% | +$83.5M | 0.61% | 32 |
|
|
2025
Q3 | $25.7M | Buy |
53,066
+892
| +2% | +$415K | 0.14% | 110 |
|
|
2025
Q2 | $21.2M | Buy |
52,174
+224
| +0.4% | +$93.7K | 0.12% | 128 |
|
|
2025
Q1 | $25.9M | Buy |
51,950
+254
| +0.5% | +$138K | 0.17% | 101 |
|
|
2024
Q4 | $27.2M | Sell |
51,696
-364
| -0.7% | -$200K | 0.17% | 92 |
|
|
2024
Q3 | $32.2M | Sell |
52,060
-128
| -0.2% | -$75.8K | 0.2% | 78 |
|
|
2024
Q2 | $28.9M | Buy |
52,188
+554
| +1% | +$317K | 0.19% | 77 |
|
|
2024
Q1 | $30M | Sell |
51,634
-42,420
| -45% | -$23.8M | 0.21% | 70 |
|
|
2023
Q4 | $49.9M | Buy |
94,054
+16,933
| +22% | +$8.2M | 0.4% | 44 |
|
|
2023
Q3 | $39M | Sell |
77,121
-8,265
| -10% | -$4.4M | 0.35% | 46 |
|
|
2023
Q2 | $44.6M | Sell |
85,386
-83,486
| -49% | -$45.1M | 0.38% | 46 |
|
|
2023
Q1 | $97.3M | Sell |
168,872
-3,956
| -2% | -$2.23M | 0.87% | 21 |
|
|
2022
Q4 | $95.2M | Buy |
172,828
+26,724
| +18% | +$14.2M | 0.91% | 21 |
|
|
2022
Q3 | $74.1M | Sell |
146,104
-491
| -0.3% | -$275K | 0.78% | 18 |
|
|
2022
Q2 | $79.6M | Buy |
146,595
+81,367
| +125% | +$44.8M | 0.79% | 18 |
|
|
2022
Q1 | $38.5M | Buy |
65,228
+8,248
| +14% | +$4.74M | 0.34% | 50 |
|
|
2021
Q4 | $38M | Buy |
56,980
+4,549
| +9% | +$2.84M | 0.29% | 54 |
|
|
2021
Q3 | $30M | Buy |
52,431
+2,485
| +5% | +$1.36M | 0.25% | 61 |
|
|
2021
Q2 | $25.2M | Sell |
49,946
-91,230
| -65% | -$43M | 0.22% | 72 |
|
|
2021
Q1 | $64.4M | Sell |
141,176
-15,732
| -10% | -$7.51M | 0.64% | 19 |
|
|
2020
Q4 | $73.1M | Sell |
156,908
-27,318
| -15% | -$12.8M | 1.1% | 9 |
|
|
2020
Q3 | $81.3M | Sell |
184,226
-4,131
| -2% | -$1.71M | 1.37% | 7 |
|
|
2020
Q2 | $68.2M | Buy |
188,357
+18,086
| +11% | +$6.06M | 1.32% | 7 |
|
|
2020
Q1 | $48.3M | Buy |
170,271
+58,990
| +53% | +$18.6M | 1.23% | 8 |
|
|
2019
Q4 | $36.2M | Buy |
111,281
+10,366
| +10% | +$3.14M | 0.8% | 20 |
|
|
2019
Q3 | $29.4M | Sell |
100,915
-12,552
| -11% | -$3.59M | 0.72% | 24 |
|
|
2019
Q2 | $33.3M | Buy |
113,467
+17,263
| +18% | +$4.75M | 0.84% | 18 |
|
|
2019
Q1 | $26.3M | Buy |
96,204
+20,435
| +27% | +$5.09M | 0.7% | 28 |
|
|
2018
Q4 | $17M | Buy |
75,769
+17,990
| +31% | +$4.22M | 0.52% | 41 |
|
|
2018
Q3 | $14.1M | Buy |
57,779
+1,573
| +3% | +$362K | 0.38% | 61 |
|
|
2018
Q2 | $11.6M | Sell |
56,206
-288
| -0.5% | -$61.1K | 0.34% | 70 |
|
|
2018
Q1 | $11.7M | Sell |
56,494
-1,762
| -3% | -$370K | 0.36% | 63 |
|
|
2017
Q4 | $11.1M | Buy |
+58,256
| New | +$11.2M | 0.34% | 68 |
|
Other funds holding TMO
VCM
Nissay Asset Management's TMO Position: Q1 2026 in Review
Nissay Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 50% in Q1 2026, selling an estimated $55M and leaving 99,415 shares worth $48.9M. The position accounts for 0.26% of the portfolio, ranked #63.
Nissay Asset Management first reported a position in TMO in Q4 2017 and has held it in 34 quarters since. The position peaked at $116M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Nissay Asset Management held 99,415 shares of Thermo Fisher Scientific worth $48.9M as of Q1 2026.
- Nissay Asset Management sold 101,333 Thermo Fisher Scientific shares in Q1 2026, an estimated $55M.
- Thermo Fisher Scientific made up 0.26% of Nissay Asset Management's portfolio in Q1 2026, its #63 holding.
- Nissay Asset Management first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 34 quarters since.
- Nissay Asset Management's Thermo Fisher Scientific position peaked at $116M in Q4 2025.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Nissay Asset Management's 13F filing for Q1 2026, filed 15 May 2026.